U.S. Supreme Court Rejects Materna Case

Law360, New York (April 19, 2004, 12:00 AM EDT) -- In a stinging blow to Wyeth, the U.S. Supreme Court has refused to hear the drug maker’s appeal of a $58.2 million patent infringement judgment awarded to the University of Colorado over the maternity supplement Materna.

The decision marks the end for Wyeth’s 10-year battle over Materna, a supplement that has earned the company hundreds of millions of dollars.

The damages award will be split between the un iversity, the professors and Competitive Technologies Inc. (CTT), a Fairfield, Conn., technology transfer company that helps universities and...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.